NeOnc CEO purchases $115,400 in stock after positive Trial results
CEO Amir Heshmatpour bought 35,000 shares for approx $115,400 on Sept 15, 2026. Execs have invested $629,000 since releasing positive phase 2a trial results.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed